Mission Statement:

Advancing medical science and public health by advocating for safe, equitable access to alternative medical treatments. Our mission is to promote the compassionate use of food-based therapies and the Introduction of New Drugs (IND) with cannabis-based treatments, alongside traditional pharmaceuticals, without stigma or legal repercussions.

​

Goal:

Our goal is to ensure patients have access to both prescribed and holistic medicines, verifying compliance with federal regulations and fostering partnerships that uphold the highest standards of safety, quality, and innovation. Together, we will create a pathway for better healthcare solutions, empowering patients and professionals alike with reliable, evidence-based options.

​

Objective:

Additional support is needed to ensure that patients have access to a wide range of prescribed medicines, the introduction of new treatments, and holistic alternatives. By working together with healthcare providers, researchers, and regulatory bodies, we can create pathways for success, ensuring that all patients receive the most effective, safe, and comprehensive care. Let’s collaborate to make this vision a reality and pave the way for greater success in patient health and wellbeing.

Additional Statement:

​

We aim to bridge the gap between healthcare providers, researchers, policymakers, and patients through evidence-based research and educational initiatives. By fostering collaboration and innovation, we work toward expanding access to life-changing therapies for those suffering from chronic pain, PTSD, anxiety, seizures, and other medical conditions.

At the core of our vision is a commitment to compassionate care, promoting reforms that ensure safe, responsible, and widespread access to alternative medical solutions. Together, we strive to improve the quality of life for individuals in need, advancing healthcare with a focus on empathy, science, and progress, that will give access to life-changing therapies.

​

The IAMB/TbT Groups are fully compliant with all regulatory requirements, having received the necessary licenses and approvals from government agencies to begin manufacturing cannabis for clinical trials. We are now actively hiring Doctors of Osteopathic Medicine, Psychiatrists, Epidemiologists, open-minded Medical Doctors, and Clinical Researchers, with a preference for new graduates and veterans.

​

Additionally, our mission is to revolutionize healthcare by introducing a more accurate and modern approach to clinical practices. The IAMB/TbT Groups are committed to advancing science and pushing the boundaries of traditional medicine, recognizing that only through rigorous research and scientific exploration can 'facts' evolve and pave the way for more effective, holistic treatment options.